“EFFICACY AND RISKS PROFILES OF ‘GLP-1 RECEPTOR AGONISTS’ IN TYPE 2 DIABETES AND OBESITY: A SYSTEMATIC REVIEW OF BENEFITS AND RISKS”. Review Journal of Neurological & Medical Sciences Review 3, no. 5 (September 28, 2025): 300–324. Accessed October 25, 2026. https://nmsreview.org/index.php/rjnmsr/article/view/382.